Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6505-11. eCollection 2015.

Abstract

Researches have revealed several stressors, which could activate unfolded protein response (UPR) in cells. However, the survival or death pathway was determined by the duration of UPR exposure. Based on the UPR mediated death pathway, our study was aimed to investigate role of UPR on c-Jun N-terminal kinase (JNK)/activator protein-1 (Ap-1) signal transduction in diindolylmethane (DIM) treated ovarian cancer cell lines. Activation of UPR proteins, UPR mediated apoptotic signaling proteins and expression level of EpCAM, JNK, Ap-1, Caspase-3 and Bcl-2 were measured. Protein and gene expression, transcription factor activity, and protein phosphorylation were measured using standard molecular biology techniques. Our results demonstrated DIM treatment had significantly increased the expression of Endoplasmic reticulum (ER) stress regulators such as Bip, IRE1, CHOP and activation of UPR related apoptotic proteins in ovarian cancer cells. Decreased expression of EpCAM and activity of AP-1 transcription factor were observed in DIM treated cells. The pharmacologic inhibitors of the JNK signal transduction pathway, suggest that the impact of EpCAM expression on AP-1 transcription factor activity is mediated through the JNK pathway. Taken together, these results suggest that UPR mediated JNK/Ap-1 signal transduction has a significant role in the regulation of apoptosis in human ovarian cancer cells, and is a potential molecular target to enhance sensitivity of ovarian cancer to chemotherapy.

Keywords: EpCAM; SKOV3 cells; diindolylmethane; endoplasmic reticulum stress.

MeSH terms

  • Antigens, Neoplasm / metabolism
  • Antineoplastic Agents / pharmacology*
  • Autophagy / drug effects
  • Caspase 3 / metabolism
  • Cell Adhesion Molecules / metabolism
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / enzymology
  • Epithelial Cell Adhesion Molecule
  • Female
  • Humans
  • Indoles / pharmacology*
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • JNK Mitogen-Activated Protein Kinases / metabolism*
  • Molecular Targeted Therapy
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / enzymology
  • Ovarian Neoplasms / pathology
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Signal Transduction
  • Time Factors
  • Transcription Factor AP-1 / metabolism*
  • Unfolded Protein Response / drug effects*

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents
  • BCL2 protein, human
  • Cell Adhesion Molecules
  • EPCAM protein, human
  • Epithelial Cell Adhesion Molecule
  • Indoles
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Transcription Factor AP-1
  • JNK Mitogen-Activated Protein Kinases
  • CASP3 protein, human
  • Caspase 3
  • 3,3'-diindolylmethane